It’s Thanksgiving week and, as most of our listeners know, it’s time when Inside Workers’ Comp celebrates our annual tradition by presenting our “Why We’re Thankful for Workers’ Comp” episode. This year, we open the floor to members of our Enlyte parent brand and pose the question to key players in our industry: Rebecca Morgan, VP, Product Management, Mitchell; Anne Levins, SVP, Network Product & Analytics, Coventry; and Debbi Gillespie, RN, CCM, Heart of Case Management Award Winner, Genex. Listen and learn why they believe this year’s Thanksgiving will be extra special for workers’ comp professionals.
More stories
Mitchell Named Official Technology Provider of the Vale Paintless Dent Repair (PDR) Technician Certification Program
Designation makes Mitchell the exclusive supplier of diagnostic and calibration tools for certified PDR technicians.
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA). Seglentis contains tramadol, a short-acting opioid, and celecoxib, a non-steroidal anti-inflammatory drug (NSAID), and is indicated for adults in the management of acute pain that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Specialty Services Are a Big Deal
When adjusters have to jump through hoops to make referrals, they lose precious time. When it comes to specialty services, we have your back.
Navigating Michigan’s No-Fault Auto Fee Schedule Four Months In
In this upcoming webinar, hear the latest from Enlyte experts on Michigan’s no-fault fee schedule, including product info and regulatory changes.
Enlyte Family of Companies Publish Inaugural Report Offering Trends and Predictions for Property & Casualty (P&C) and Collision Repair Industries
Under its new parent brand, Mitchell, Genex and Coventry launch first edition of Enlytened, examining continuing impact of COVID-19 on innovation and technology